Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 23;12(1):4506.
doi: 10.1038/s41467-021-24082-z.

Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores

Affiliations

Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores

Ganna Leonenko et al. Nat Commun. .

Abstract

Polygenic Risk Scores (PRS) for AD offer unique possibilities for reliable identification of individuals at high and low risk of AD. However, there is little agreement in the field as to what approach should be used for genetic risk score calculations, how to model the effect of APOE, what the optimal p-value threshold (pT) for SNP selection is and how to compare scores between studies and methods. We show that the best prediction accuracy is achieved with a model with two predictors (APOE and PRS excluding APOE region) with pT<0.1 for SNP selection. Prediction accuracy in a sample across different PRS approaches is similar, but individuals' scores and their associated ranking differ. We show that standardising PRS against the population mean, as opposed to the sample mean, makes the individuals' scores comparable between studies. Our work highlights the best strategies for polygenic profiling when assessing individuals for AD risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Effects of APOE allele frequencies and age on genetic risk scores.
A Allele ε4, ε3, ε2 frequencies (red, orange and green lines respectively) in the case-control dataset (271 cases and 278 controls), B, C the mean risk score for ε4 allele frequencies, ORS.no.APOE and PRS.no.APOE (red, green and blue lines respectively) split by age groups. ORS.no.APOE includes SNPs with p-value≤ 1e-5, PRS.no.APOE includes SNPs with p-value ≤ 0.1 and both exclude the APOE region. A represents the full sample (B) represents cases only and (C) controls only. Age groups are specified as (55–65, 65–75, 75–85, 85+). For comparability of the scores in (B, C) the e4 genotypes (originally coded as 0/1/2) were also standardised. ORS Oligogenic risk score, PRS Polygenic risk score, SNP Single nucleotide polymorphism.
Fig. 2
Fig. 2. Prediction accuracy across different PRS methods (PRS(C + T), PRSice, LDpred-Inf, PRS-CS, LDAK and SBayesR) for ORS.full, ORS.no.APOE, PRS.full, PRS.no.APOE and PRS.AD.
Bar plot for prediction accuracy (AUC and R2) across 6 PRS approaches: PRS(C + T), PRSice, LDpred-Inf, PRS-CS, LDAK and SBayesR (red, yellow, green, teal, blue, pink bars respectively). The colour of each PRS method is consistent across all plots. Upper figures represent ORS and lower figures represent PRS and PRS.AD models in the case-control dataset (271 cases and 278 controls). ORS.full includes SNPs with pT ≤ 1e-5 and PRS.full includes SNPs with pT ≤ 0.1, ORS.no.APOE and PRS.no.APOE exclude SNPs in the APOE region and PRS.AD models APOE separately and subsequently adds this to PRS.no.APOE. AUC Area Under the Curve, ORS Oligogenic risk score, PRS Polygenic risk score, AD Alzheimer’s Disease, SNP Single nucleotide polymorphism.

References

    1. Sperling, R. A. et al. Toward defining the PRECLINICAL stages of Alz Disease: recommendations from the NIAGING-ALZ ASSO workgroups on DX guidelines for AD. Alzheimers. Dement. (2011). 10.1016/j.jalz.2011.03.003 - PMC - PubMed
    1. Livingston, G. et al. Dementia prevention, intervention, and care. Lancet (2017). 10.1016/S0140-6736(17)31363-6
    1. Craik, F. I. M., Bialystok, E. & Freedman, M. Delaying the onset of Alzheimer disease: Bilingualism as a form of cognitive reserve. Neurology (2010). 10.1212/WNL.0b013e3181fc2a1c - PMC - PubMed
    1. Vemuri, P. et al. Effect of intellectual enrichment on AD biomarker trajectories. Neurology (2016). 10.1212/WNL.0000000000002490 - PMC - PubMed
    1. Wilson, R. S. et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. J. Am. Med. Assoc. (2002). 10.1001/jama.287.6.742 - PubMed

Publication types

MeSH terms

Substances